Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)

NCT00048607 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)

NCT00035048 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)

NCT00034983 ·Status: COMPLETED ·Phase: PHASE3

Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)

NCT00610649 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

NCT04937829 ·Status: COMPLETED ·Phase: PHASE1

This is a Study to Determine the Antidepressant Effects of AZD6765

NCT00986479 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01111552 ·Status: TERMINATED ·Phase: PHASE3

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

NCT01380704 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01111539 ·Status: TERMINATED ·Phase: PHASE3

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

NCT06785012 ·Status: RECRUITING ·Phase: PHASE2

Clinical Study to Test a New Drug to Treat Major Depression

NCT00976560 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

NCT06966401 ·Status: RECRUITING ·Phase: PHASE3

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

NCT01098240 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

NCT01034462 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

NCT00969709 ·Status: COMPLETED ·Phase: PHASE3

Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder

NCT00593879 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

NCT01741142 ·Status: TERMINATED ·Phase: PHASE2

A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder

NCT00733980 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

NCT06786624 ·Status: RECRUITING ·Phase: PHASE3

Effectiveness of Pramipexole for Treatment-Resistant Depression

NCT00231959 ·Status: COMPLETED ·Phase: PHASE4

Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)

NCT00759395 ·Status: COMPLETED ·Phase: PHASE2

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

NCT06911112 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

NCT04663321 ·Status: TERMINATED ·Phase: PHASE2

An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder

NCT00358631 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

NCT05203341 ·Status: COMPLETED ·Phase: PHASE2